中文版
js_thumb bannerPic
/
Tumor-targeted drug gene testing

Technical Services

Tumor-targeted drug gene testing

Description:Tumor-targeted therapy is the selective delivery of drugs to the tumor site, limiting the therapeutic effect or drug effect to specific target cells, tissues or organs as much as possible without affecting the function of normal cells, tissues or organs, thereby improving the efficacy, A way to reduce toxic side effects.
Description:Tumor-targeted therapy is the selective delivery of drugs to the tumor site, limiting the therapeutic effect or drug effect to specific target cells, tissues or organs as much as possible without affecting the function of normal cells, tissues or organs, thereby improving the efficacy, A way to reduce toxic side effects.
Information

Tumor-targeted drug gene testing

Tumor-targeted therapy is the selective delivery of drugs to the tumor site, limiting the therapeutic effect or drug effect to specific target cells, tissues or organs as much as possible without affecting the function of normal cells, tissues or organs, thereby improving the efficacy, A way to reduce toxic side effects. The effectiveness of targeted drug therapy in clinical application varies greatly from individual to individual. Some cases work well, and some cases may not be effective. If the cancer-targeted drug-related genes are detected in the early stage of their treatment, the specific situation of their genetic mutations is of great significance for the selection of tumor-targeted therapeutic drugs.

This product uses fluorescence quantitative PCR and Sanger sequencing methods to detect mutations in genes related to targeted drugs commonly used in tumors in the NCCN guidelines, analyze the impact of gene mutations on drug efficacy, and assist doctors in developing the most appropriate individualized treatment plan.

 

Product ID

Product name

Detection cycle

Sample type

T1

EGFR gene detection (20/29/50 mutants)

3 working days

Fresh tissue, paraffin section, paraffin roll, puncture tissue, pleural fluid (lung cancer), peripheral blood (Streck Cell-Free DNA blood collection tube)

T2

KRAS gene detection (8 mutants)

3 working days

T3

BRAF V600E gene test

3 working days

T4

ALK-EML4 fusion mutation detection

3 working days

Fresh tissue, paraffin section, paraffin roll, puncture tissue

T5

ROS1 rearrangement gene detection

3 working days

T6

NRAS gene test

7 working days

T7

MET gene test

7 working days

Paraffin section

T8

HER2 amplification test

7 working days

T9

c-KIT + PDGFRA gene detection

7 working days

 

  

Keyword: gene working paraffin drug

Scan the QR code to read on your phone

Search
Search

Suzhou Office: Building 1, No. 188, Fuchunjiang Road, High-tech Zone, Suzhou
Beijing Office: Building 2, No. 28, Yuhua Road, Airport Science and Technology Park, Shunyi District, Beijing
Contact number:
+86-10-80497001
Nantong Office: No. 888 Zhujiang Road, Juegang Street, Rudong County, Jiangsu Province
Contact number:
+86-513-80562882
Company email: info@hongweitest.com

Macro micro-test

WeChat

Copyright © 2021 Jiangsu Macro & Micro-Test Med-Tech Co.,Ltd.苏ICP备18057655号 苏公网安备 32062302000215号 Power by:300.cn
Suspended
返回顶部